Company Analysis

Krystal Biotech, Inc. (KRYS)

Nasdaq: KRYS · Biological Products, (No Diagnostic Substances) · Pittsburgh, PA · filing with the SEC since 2017
Grade7.6
◀ Past 7.1● Present 9.0▶ Future 6.1

Who runs Krystal Biotech, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Krishnan Krish S
President and CEO. First filing Sep 2017, latest Sep 4, 2026, 29 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
17 people on the record since 2017
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Krishnan Krish SPresident and CEOSep 2017Sep 4, 202650 · $34.3M
Krishnan SumaPresident, R&DSep 2017Sep 4, 202650 · $34.3M
Thomas John CharlesEVP, General CounselMar 2026Jun 26, 20262 · $500,000
Goux Laurent Louis JeanEVP, Head of InternationalMar 2026Mar 6, 2026none
Romano KathrynChief Accounting OfficerFeb 2020Mar 3, 20268 · $3.6M
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gangolli Julian SdirectorMar 2019Sep 16, 2026none
Janney DanieldirectorSep 2017Sep 16, 202622 · $19.4M
Mason ChristopherdirectorJan 2021Sep 16, 2026none
Mazzacco CatherinedirectorMar 2023Sep 16, 2026none
Rossi Dino AdirectorSep 2017Sep 16, 202610 · $13.2M
Sutherland Everett RanddirectorJan 2022Sep 16, 2026none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton KRYS · research, not advice